Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06070870 · ClinicalTrials.gov registry record · NA

Health Education Approach to Lung Screening

A NA study of Lung Cancer, sponsored by Virginia Commonwealth University.

Recruiting
Registry status
NA
Development phase
675
Enrollment target
3
Study locations

NCT06070870 is a NA study of Lung Cancer that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 675 participants, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (28% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06070870, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Virginia Commonwealth University.

RECRUITING
Registry status
NA
Development phase
675 participants
Enrollment target
3
Study locations

Study Summary

Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)

Conditions Studied

Interventions

  • BEHAVIORAL Patient Navigation

Study Locations (3)

North Carolina

  • University of North Carolina-Chapel Hill - Carrboro

South Carolina

  • Medical University of South Carolina - Charleston

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 675 participants
Start Date 2023-10-10
Est. Completion 2027-04-30
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT06070870

The ClinicalTrials.gov registry entry for NCT06070870 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 675 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (28% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Patient Navigation is the first listed.

NCT06070870 reports 3 study locations spanning 3 distinct geographic areas - top geographies include North Carolina, South Carolina, Virginia.

Frequently Asked Questions

What is clinical trial NCT06070870 about?

NCT06070870 is a clinical study titled "Health Education Approach to Lung Screening". Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)

What is the current status of trial NCT06070870?

This trial is currently recruiting. It is a NA study. The enrollment target is 675 participants. The study started on 2023-10-10. Estimated completion is 2027-04-30.

What conditions does trial NCT06070870 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT06070870?

The interventions under investigation include: Patient Navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06070870?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06070870 being conducted?

This trial has 3 study locations across North Carolina, South Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.